THE BEST CARE IS INTEGRATED CARE
Integration drives employee health
Prime’s peer-reviewed study shows an average savings of $148 per member per year on medical costs, 7% lower odds of emergency room visits and 15% lower odds of hospitalization.1
Integration helps keep people safe from opioid overuse
For one large employer group, integrated data from Blue + Prime pharmacy claims helped decrease high opioid use for 1 in 3 employees — and even helped prevent one potential employee opioid overdose.²
Horizon Pharmacy + Prime
Our radically different model allows us to redefine integration as we harness our collective Horizon Pharmacy + Prime knowledge to unlock better, more affordable care through a customizable approach that offers you true flexibility and transparency.
Prioritize the health of your employees and your group’s bottom line with drug benefit recommendations backed by integrated data and intelligence.
Integrated for channel independence
Choose any path that best serves your employees, prioritizing affordability, quality and customer service through any channel you and they prefer.
Integrated employee experience
Provide employee-centric solutions at each step of their journeys, integrating seamlessly into their overall care experience thanks to Horizon Pharmacy + Prime’s deep integration.
Work with a partner whose goals are your goals. Horizon Pharmacy + Prime is focused on your needs first, striving to help you lower costs, deliver seamless service and support the health of your employees.
Horizon Blue Cross Blue Shield of New Jersey is an independent licensee of the Blue Cross Blue Shield Association. The Blue Cross® and Blue Shield® names and symbols are registered marks of the Blue Cross Blue Shield Association. The Horizon® name and symbols are registered marks of Horizon Blue Cross Blue Shield of New Jersey.
¹ Lam S, Gleason PP, et.al.(2020). Medical costs and health care utilization among self-insured members with carve-in versus carve-out pharmacy benefits. J Manag Care Spec Pharm, 26(6),766-774 https://www.jmcp.org/doi/full/10.18553/jmcp.2020.19411
² Prime analysis 2021